We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Genes Identified that Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin

News   Apr 22, 2009

 
Genes Identified that Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin
 
 
Advertisement
 

RELATED ARTICLES

More Turkey for Celiac Disease Sufferers?

News

People with celiac disease may find themselves more comfortable with extra Thanksgiving turkey. Researchers have found that tryptophan, an amino acid present in high amounts in turkey, combined with some probiotics, may help them heal and respond better to a gluten-free diet.

READ MORE

Major Step Toward Angelman Syndrome Gene Therapy

News

Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe neurodevelopmental disorder with no cure and limited treatments. Now, for the first time, scientists at the UNC School of Medicine show that gene editing and gene therapy techniques can be used to restore UBE3A in human neuron cultures and treat deficits in an animal model of Angelman syndrome.

READ MORE

A Potential Diagnostic Test and Molecular Target for Machado-Joseph Disease

News

Researchers have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3), a disease that currently has no cure. The team has also have uncovered the role of a gene target linked to the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE